Roberto Brian Minero, FNP-C

Roberto Minero practices at Afc Urgent Care Of Santa Clarita in Valencia, California.

Roberto Minero's NPI, 1972299857, was assigned on April 13, 2023. Roberto Minero holds California license 95024601.

Roberto Minero's primary practice is Afc Urgent Care of Santa Clarita, at 27550 Newhall Ranch Rd, Suite 203, Valencia, CA 91355-6049. The practice phone is (661) 251-6300.

Roberto Minero's primary practice is Afc Urgent Care Of Santa Clarita in Valencia, California. The medical group on file is AFC Urgent Care of Santa Clarita.

Dmand AI tracks the electronic health record (EHR) system at each site where Roberto Minero practices. Vendor and product names are available with a free account.

Family is Roberto Minero's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Roberto Minero is licensed in California.

Dmand AI lists contact dermatitis, depression, scalp rash and upper respiratory infection (URI) among the conditions Roberto Minero treats.

CMS data shows 301 Medicare services from Roberto Minero across 12 procedure codes in 2024, for 148 Medicare patients. Medicare paid $15,499 for them. Every service was in an office.

CMS counts 148 Medicare patients who saw Roberto Minero in 2024. The largest group is 65 to 74, with 79 patients. 72% of them have high cholesterol, and 64% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Roberto Minero's median patient age at 38, with 56% women.

In 2024, Roberto Minero wrote 481 Medicare Part D claims for 219 patients. 86% of them were for generic drugs. CMS names the drug for 227 of them, across 12 drugs with 11 or more claims each, at $10,381 in total drug cost.

Roberto Minero accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Roberto Minero from 5 drug and device companies in 2024. Food and beverage make up the largest share, 98% of the total. Eli Lilly and Company paid the most, $178.